Buzzai M - Search Results

1

miR-433 is aberrantly expressed in myeloproliferative neoplasms and suppresses hematopoietic cell growth and differentiation.

Lin X, Rice KL, Buzzai M, Hexner E, Costa FF, Kilpivaara O, Mullally A, Soares MB, Ebert BL, Levine R, Licht JD. Lin X, et al. Among authors: buzzai m. Leukemia. 2013 Feb;27(2):344-52. doi: 10.1038/leu.2012.224. Epub 2012 Aug 6. Leukemia. 2013. PMID: 22864358

2

New molecular concepts and targets in acute myeloid leukemia.

Buzzai M, Licht JD. Buzzai M, et al. Curr Opin Hematol. 2008 Mar;15(2):82-7. doi: 10.1097/MOH.0b013e3282f3ded0. Curr Opin Hematol. 2008. PMID: 18300752 Review.

3

Analysis of genomic aberrations and gene expression profiling identifies novel lesions and pathways in myeloproliferative neoplasms.

Rice KL, Lin X, Wolniak K, Ebert BL, Berkofsky-Fessler W, Buzzai M, Sun Y, Xi C, Elkin P, Levine R, Golub T, Gilliland DG, Crispino JD, Licht JD, Zhang W. Rice KL, et al. Among authors: buzzai m. Blood Cancer J. 2011 Nov;1(11):e40. doi: 10.1038/bcj.2011.39. Epub 2011 Nov 11. Blood Cancer J. 2011. PMID: 22829077 Free PMC article.

4

Transcriptional profiling of polycythemia vera identifies gene expression patterns both dependent and independent from the action of JAK2V617F.

Berkofsky-Fessler W, Buzzai M, Kim MK, Fruchtman S, Najfeld V, Min DJ, Costa FF, Bischof JM, Soares MB, McConnell MJ, Zhang W, Levine R, Gilliland DG, Calogero R, Licht JD. Berkofsky-Fessler W, et al. Among authors: buzzai m. Clin Cancer Res. 2010 Sep 1;16(17):4339-52. doi: 10.1158/1078-0432.CCR-10-1092. Epub 2010 Jul 2. Clin Cancer Res. 2010. PMID: 20601445 Free PMC article.

5

Akt stimulates aerobic glycolysis in cancer cells.

Elstrom RL, Bauer DE, Buzzai M, Karnauskas R, Harris MH, Plas DR, Zhuang H, Cinalli RM, Alavi A, Rudin CM, Thompson CB. Elstrom RL, et al. Among authors: buzzai m. Cancer Res. 2004 Jun 1;64(11):3892-9. doi: 10.1158/0008-5472.CAN-03-2904. Cancer Res. 2004. PMID: 15172999

6

The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation.

Buzzai M, Bauer DE, Jones RG, Deberardinis RJ, Hatzivassiliou G, Elstrom RL, Thompson CB. Buzzai M, et al. Oncogene. 2005 Jun 16;24(26):4165-73. doi: 10.1038/sj.onc.1208622. Oncogene. 2005. PMID: 15806154

7

How do cancer cells acquire the fuel needed to support cell growth?

Thompson CB, Bauer DE, Lum JJ, Hatzivassiliou G, Zong WX, Zhao F, Ditsworth D, Buzzai M, Lindsten T. Thompson CB, et al. Among authors: buzzai m. Cold Spring Harb Symp Quant Biol. 2005;70:357-62. doi: 10.1101/sqb.2005.70.011. Cold Spring Harb Symp Quant Biol. 2005. PMID: 16869772

8

AMP-activated protein kinase induces a p53-dependent metabolic checkpoint.

Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y, Birnbaum MJ, Thompson CB. Jones RG, et al. Among authors: buzzai m. Mol Cell. 2005 Apr 29;18(3):283-93. doi: 10.1016/j.molcel.2005.03.027. Mol Cell. 2005. PMID: 15866171 Free article.

9

Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth.

Fei P, Wang W, Kim SH, Wang S, Burns TF, Sax JK, Buzzai M, Dicker DT, McKenna WG, Bernhard EJ, El-Deiry WS. Fei P, et al. Among authors: buzzai m. Cancer Cell. 2004 Dec;6(6):597-609. doi: 10.1016/j.ccr.2004.10.012. Cancer Cell. 2004. PMID: 15607964 Free article.

10

Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth.

Buzzai M, Jones RG, Amaravadi RK, Lum JJ, DeBerardinis RJ, Zhao F, Viollet B, Thompson CB. Buzzai M, et al. Cancer Res. 2007 Jul 15;67(14):6745-52. doi: 10.1158/0008-5472.CAN-06-4447. Cancer Res. 2007. PMID: 17638885 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters